DIN 02322323 — SANDOZ NARATRIPTAN 2.5 MG
SANDOZ NARATRIPTAN is a tablet of Naratriptan marketed by SANDOZ CANADA INCORPORATED. The full Naratriptan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02322323
- Brand name
- SANDOZ NARATRIPTAN
- Active ingredient
- Naratriptan
- Strength
- 2.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Selective serotonin 5-HT1B/1D receptor agonist (triptan)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Naratriptan products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02314290 | TEVA-NARATRIPTAN | 1 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02314304 | TEVA-NARATRIPTAN | 2.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |